Calmer Co International Limited · ASX:CCO
Calmer Co International — The Calmer Co. International — Q4 FY26 Earnings Presentation
15 slides from Calmer Co International's earnings presentation, Jul 31, 2026
Slide 1: Q4 FY26 Results Investor Webinar
For personal use only ASX: CCO | QUARTERLY ACTIVITIES REPORT Q4 FY26 Results Investor Webinar Friday, 7 August 2026 | 11:00am AEST Presented by Zane Yoshida, Founder & CEO The Calmer Co. International Limited | thecalmerco.com
Slide 2: Webinar Agenda
WEBINAR AGENDA What we'll cover today For personal use only 01 Strategic pillars Where we are against our four growth engines 02 Quarterly highlights Headline numbers and the story behind them 03 Revenue performance Geography, channel and product format breakdown 04 Retail momentum The 24% step-up r
Slide 3: Four pillars driving The Calmer Co.
OUR STRATEGIC FRAMEWORK Four pillars driving The Calmer Co. The world's leading natural relaxation company · Q4 FY26 progress at a glance For personal use only Regional Sourcing Direct to Consumer 01 02 & Innovation (incl. Amazon) Pacific Island regional sourcing Q4 PROGRESS Amazon USA & AU marketpl
Slide 4: Q4 FY26 highlights
QUARTER AT A GLANCE Q4 FY26 highlights For personal use only $1.72m +24% +22% +15% Q4 group revenue Retail growth QoQ Australia revenue QoQ Cash receipts QoQ Retail-led quarter; wholesale reflecting $779,879 — now the largest channel at $965,922, or ~56% of group revenue. Receipts from customers of
Slide 5: Revenue rebalances as retail steps up
FINANCIAL OVERVIEW Revenue rebalances as retail steps up For personal use only LARGEST CHANNEL $780k Quarterly group revenue Retail growth partially offsetting the timing of wholesale orders $1.96m $1.72m Retail revenue for the quarter — up 24% and 45% of group sales. What's behind the result –12% Q
Slide 6: Australia steps forward, now ~56% of group revenue
SALES BY GEOGRAPHY Australia steps forward, now ~56% of group revenue For personal use only Australia & New Zealand +22% QoQ $966k Retail-led growth; Fiji Kava® leads the Coles stress category. AUS United States 41% of revenue 56% $696k E-commerce and wholesale led; retail brokerage agreement now in
Slide 7: Retail becomes our largest channel
SALES BY CHANNEL Retail becomes our largest channel For personal use only Retail E-commerce Wholesale $779,879 $630,692 $305,740 45% of revenue · +24% QoQ 37% of revenue 18% of revenue · order timing ● Largest channel for the quarter, led by Coles ● Amazon USA delivered $457,133 in Q4 sales ● Reflec
Slide 8: The 24% step-up reshaping our channel mix
RETAIL MOMENTUM The 24% step-up reshaping our channel mix For personal use only WHY IT MATTERS Retail revenue increased 24% QoQ Now ~45% of group revenue and our largest channel for the quarter. A stronger base $780k Mainstream adoption. $629k +24% QoQ Fiji Kava® 150g and 50g lead the Coles stress c
Slide 9: Powder-led quarter as retail scales
SALES BY PRODUCT FORMAT Powder-led quarter as retail scales For personal use only Q4 FY26 revenue by product format EXTRACTS — HIGHER-VALUE PLATFORM Kava powder 80% 16% Kava extracts 16% Share of group revenue (Q3 FY26: 21%) RTD ~2% Q4 FY26 Why it matters $1.72m Medicinal ~1% Higher value per kilogr
Slide 10: Improving cash performance, disciplined spend
CASH, COSTS & FUNDING Improving cash performance, disciplined spend For personal use only $633k $1.88m $1.5m –9% Cash on hand Cash receipts from customers Inventory (incl. prepaid) Net operating cash outflow At 30 June 2026 quarter end. Up 15% quarter-on-quarter. Maintained to support demand into FY
Slide 11: Input cost recovery flowing through from FY27
MARGIN & INPUT COSTS Input cost recovery flowing through from FY27 For personal use only Input costs and margin recovery MARGIN RECOVERY Higher kava input costs Measures take full effect in Raw material costs increased across H2 FY26, weighing on gross margin. FY27 Recovery tied to retail pricing H2
Slide 12: Category tailwinds across our key markets
REGULATORY LANDSCAPE Category tailwinds across our key markets For personal use only Australia United States International TGA · ODC · FSANZ FDA · DSHEA · State agencies Codex · EU · UK · NZ Commercial Import Pilot. Dietary supplement framework. Codex CXS 336R-2020. Phase 2 commenced Dec 2021, allow
Slide 13: Entering FY27 with a stronger base and a clear plan
LOOKING AHEAD Entering FY27 with a stronger base and a clear plan For personal use only Strategic priorities for FY27 MARKET OPPORTUNITY Expand wholesale & B2B Natural relaxation, globally Convert the growing pipeline into recurring orders across powder and CO₂ extract formats. Build on retail momen
Slide 14: A stronger, more diversified base
FROM THE CEO A stronger, more diversified base “ For personal use only The June quarter demonstrated the growing strength of our diversified channel strategy, with Australian retail revenue increasing 24% quarter-on-quarter to approximately $780,000 — supported by improved supply execution, recently
Slide 15: Questions & next steps
THANK YOU Questions & next steps For personal use only Q4 FY26 INVESTOR WEBINAR INVESTOR & MEDIA RELATIONS Zane Yoshida Open Q&A with the CEO Founder & CEO Join Zane Yoshida to discuss Q4 FY26 performance, activities and focus. investors@thecalmerco.com ABOUT THE CALMER CO. DATE Friday, 7 August 202
The Calmer Co. International — Q4 FY26 Earnings Presentation on 6ix